Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Molecular Biology Blocked-cholecalciferol-and-dihydrotachysterol-3-derivatives

 Fuel separator system
The present invention is a float actuated control to drain water from a fuel tank without loss of ...


 Methods and nucleic acid sequences for the expression of the cellulose synthase operon
The present invention provides an operon associated with the biosynthesis of cellulose, ...


 Method for preparing adenosine triphosphate
We claim: 1. A method of preparing adenosine triphosphate in an enzyme-catalyzed reaction, said ...


 Cancer detection procedure using an acyl carrier protein
OF THE PREFERRED EMBODIMENT The present diagnostic procedure is based upon the finding that ...


 Process for the preparation of vanillin
What is claimed is: 1. A process for the preparation of vanillin which comprises oxidizing in a ...


 Bioconversion process for the production of vanillin
We claim: 1. A process for the production of vanillin comprising contacting a bioconversion mixture ...


 DNA encoding histidyl tRNA synthetase variant from Streptococcus pneumoniae
What is claimed is: 1. An isolated polynucleotide comprising a polynucleotide sequence selected ...


 Process for production of ascorbate oxidase
What is claimed is: 1. A process for the production of ascorbate oxidase, comprising contacting ...


 Bactericidal factor in human airway surface fluid and uses thereof
This invention relates to a broad spectrum antimicrobial factor which is produced by airway ...


 N-substituted cyclopeptide derivatives and preparation thereof
We claim: 1. A process for preparing a compound of formula I ##STR4## in which R.sup.1 is lower ...


 Blocked cholecalciferol and dihydrotachysterol 3 derivatives

Details
Inventors: Jones, Howard; Yang, Shu Shu; Jacobus, David P.;
Assignee: Merck & Co., Inc. (Rahway, NJ)
Primary Examiner: Roberts; Elbert L.
Assistant Examiner:
Attorney, Agent or Firm: Anderson, Jr.; Rudolph J., Westlake, Jr.; Harry E., Mahon; Frank M.

Novel cholecalciferol and dihydrotachysterol.sub.3 derivatives produced against metabolic conversions at the 25-position, their preparation, pharmaceutical compositions, methods of treating steroid-induced osteoporosis, senile osteoporosis and secondary hyperparathyroidism, especially that induced by an insufficient amount of calcium in relationship to the amount of phosphate, novel intermediates and their preparation are disclosed.

DETAILED DESCRIPTION We have found that cholecalciferol and dihydrotachysterol.
sub.
3 and their derivatives may be metabolically blocked by the presence of a halo or O-C.
sub.
1-5 alkyl carbamate group in the 25-position.
These compounds may also be metabolically blocked in the 3- and/or 24-positions, in addition to the 25-position, with either a halo or O-C.
sub.
1-5 alkyl carbamate group.
The presence of one or more of the groups listed above retards metabolic hydroxylation in vivo in the blocked position(s).
These novel metabolically blocked compounds promote intestinal-calcium transport as opposed to bone-calcium mobilization.
The novel metabolically-blocked cholecalciferol and dihydrotachysterol.
sub.
3 compounds of this invention have the following structural formulae: ##STR1## wherein: R.
sub.
1, is hydrogen, hydroxy, C.
sub.
1-5 alkanoyloxy, such as acetoxy or propionyloxy, substituted C.
sub.
1-5 alkanoyloxy, such as haloC.
sub.
1-5 alkanoyloxy (bromoacetoxy) or branchedC.
sub.
3-5 alkanoyloxy (isopropionyloxy), benzoyloxy or substituted benzoyloxy, such as p-nitrobenzoyloxy, R.
sub.
3, r.
sub.
24 and R.
sub.
25 are hydrogen, hydroxy, C.
sub.
1-5 alkanoyloxy, such as acetoxy or propionyloxy, substituted C.
sub.
1-5 alkanoyloxy, such as haloC.
sub.
1-5 alkanoyloxy (bromoacetoxy) or branchedC.
sub.
3-5 alkanoyloxy (isopropionyloxy), benzoyloxy, substituted benzoyloxy, such as p-nitrobenzoyloxy, halo, such as chloro, bromo, iodo and especially fluoro or O--C.
sub.
1-5 alkyl carbamate, such as O-methyl carbamate, O-ethyl carbamate or O-isopropyl carbamate with the proviso that R.
sub.
25 must be halo or O--C.
sub.
1-5 alkyl carbamate.
O--C.
sub.
1-5 Alkyl carbamates have the following structure: ##STR2## In a preferred embodiment, R.
sub.
1, R.
sub.
3 and R.
sub.
24 are hydrogen or hydroxy.
In a more preferred embodiment, R.
sub.
25 is fluoro.
The novel compounds of formula I are named as derivatives of cholecalciferol.
Cholecalciferol is also known as vitamin D.
sub.
3, activated 7-dehydrocholesterol and 9,10-seco-5,7,10(19)-cholestatrien-3



Related patents
  4-[(Carboxyl- and sulfamyl-substituted alkyl)-amino] benzoic acids and analogs
OF THE INVENTION The compounds of the invention are new and novel 4-[(carboxyl- and sulfamyl-substituted alkyl)amino]benzoic acids and analogs which have ...
  Vaccine production
What is claimed is: 1. In a process for the controlled manufacture of vaccines wherein cells are grown in a glucose containing nutrient medium and infected with a virus, ...
  Method of fermenting brewer's wort
We claim: 1. The method of preparing an alocholic beverage, comprising the steps of preparing an aqueous fermentable substrate containing fermentable carbohydrates and ...
  Treatment of hemorrhagic shock
I claim: 1. A method of treating shock in humans to reverse the same and elevate blood pressure which comprises intravenously administering to a patient in need thereof ...
  Compositions comprising alkylpolysaccharide detergent surfactant
What is claimed is: 1. A homogeneous granular detergent composition comprising: (1) from about 2% to about 30% of alkylpolysaccharide detergent surfactant having the ...
  Process for the preparation of a mixture of sucrose oxidation products and the use thereof
We claim: 1. A process for the preparation of a mixture of sucrose oxidation products which comprises a salt of sucrosetricarboxylic acid comprising reacting sucrose ...
  Process for making a high density detergent composition from starting detergent ingredients
OF THE PREFERRED EMBODIMENT The present process is used in the production of low dosage detergent agglomerates directly from starting detergent ingredients rather than ...
  Aqueous alkaline composition
OF THE INVENTION In Formula I a is from 2.5 to 7, preferably from 3 to 6.5, more preferably from 3.5 to 6, most preferably, a is higher than b. In Formula II c is from 0...
  Stereospecific keto reduction of bicyclooctandione-carboxylic acid esters by microorganisms
What is claimed is: 1. A process for the production of a 3.alpha.-hydroxy prostacyclin intermediate product of the formula (+)-I ##STR7## wherein A is the radical >CH-...
  Automatic sludge extraction and washing device for use in a water treatment settling apparatus
With the above discussion in mind, it is the primary object of the present invention to provide a device for selectively automatically extracting sludge from a ...

0.044

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved